Global Marine Drug Market Size, Status and Forecast 2020-2026

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Marine Drug Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Marine Drug Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Drugs
  • 1.4.3 Health Supplement
• 1.5 Market by Application
  • 1.5.1 Global Marine Drug Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital & Clinic
  • 1.5.3 Pharmacy
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends by Regions

• 2.1 Marine Drug Market Perspective (2015-2026)
• 2.2 Marine Drug Growth Trends by Regions
  • 2.2.1 Marine Drug Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Marine Drug Historic Market Share by Regions (2015-2020)
  • 2.2.3 Marine Drug Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Marine Drug Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Marine Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Marine Drug Players by Market Size
  • 3.1.1 Global Top Marine Drug Players by Revenue (2015-2020)
  • 3.1.2 Global Marine Drug Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Marine Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Marine Drug Market Concentration Ratio
  • 3.2.1 Global Marine Drug Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Marine Drug Revenue in 2019
• 3.3 Marine Drug Key Players Head office and Area Served
• 3.4 Key Players Marine Drug Product Solution and Service
• 3.5 Date of Enter into Marine Drug Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Marine Drug Historic Market Size by Type (2015-2020)
• 4.2 Global Marine Drug Forecasted Market Size by Type (2021-2026)

5 Marine Drug Breakdown Data by Application (2015-2026)

• 5.1 Global Marine Drug Market Size by Application (2015-2020)
• 5.2 Global Marine Drug Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Marine Drug Market Size (2015-2020)
• 6.2 Marine Drug Key Players in North America (2019-2020)
• 6.3 North America Marine Drug Market Size by Type (2015-2020)
• 6.4 North America Marine Drug Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Marine Drug Market Size (2015-2020)
• 7.2 Marine Drug Key Players in Europe (2019-2020)
• 7.3 Europe Marine Drug Market Size by Type (2015-2020)
• 7.4 Europe Marine Drug Market Size by Application (2015-2020)

8 China

• 8.1 China Marine Drug Market Size (2015-2020)
• 8.2 Marine Drug Key Players in China (2019-2020)
• 8.3 China Marine Drug Market Size by Type (2015-2020)
• 8.4 China Marine Drug Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Marine Drug Market Size (2015-2020)
• 9.2 Marine Drug Key Players in Japan (2019-2020)
• 9.3 Japan Marine Drug Market Size by Type (2015-2020)
• 9.4 Japan Marine Drug Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Marine Drug Market Size (2015-2020)
• 10.2 Marine Drug Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Marine Drug Market Size by Type (2015-2020)
• 10.4 Southeast Asia Marine Drug Market Size by Application (2015-2020)

11 India

• 11.1 India Marine Drug Market Size (2015-2020)
• 11.2 Marine Drug Key Players in India (2019-2020)
• 11.3 India Marine Drug Market Size by Type (2015-2020)
• 11.4 India Marine Drug Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Marine Drug Market Size (2015-2020)
• 12.2 Marine Drug Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Marine Drug Market Size by Type (2015-2020)
• 12.4 Central & South America Marine Drug Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Seattle Genetics
  • 13.1.1 Seattle Genetics Company Details
  • 13.1.2 Seattle Genetics Business Overview and Its Total Revenue
  • 13.1.3 Seattle Genetics Marine Drug Introduction
  • 13.1.4 Seattle Genetics Revenue in Marine Drug Business (2015-2020))
  • 13.1.5 Seattle Genetics Recent Development
• 13.2 DSM
  • 13.2.1 DSM Company Details
  • 13.2.2 DSM Business Overview and Its Total Revenue
  • 13.2.3 DSM Marine Drug Introduction
  • 13.2.4 DSM Revenue in Marine Drug Business (2015-2020)
  • 13.2.5 DSM Recent Development
• 13.3 Eisai Co
  • 13.3.1 Eisai Co Company Details
  • 13.3.2 Eisai Co Business Overview and Its Total Revenue
  • 13.3.3 Eisai Co Marine Drug Introduction
  • 13.3.4 Eisai Co Revenue in Marine Drug Business (2015-2020)
  • 13.3.5 Eisai Co Recent Development
• 13.4 Takeda
  • 13.4.1 Takeda Company Details
  • 13.4.2 Takeda Business Overview and Its Total Revenue
  • 13.4.3 Takeda Marine Drug Introduction
  • 13.4.4 Takeda Revenue in Marine Drug Business (2015-2020)
  • 13.4.5 Takeda Recent Development
• 13.5 BASF
  • 13.5.1 BASF Company Details
  • 13.5.2 BASF Business Overview and Its Total Revenue
  • 13.5.3 BASF Marine Drug Introduction
  • 13.5.4 BASF Revenue in Marine Drug Business (2015-2020)
  • 13.5.5 BASF Recent Development
• 13.6 Amway
  • 13.6.1 Amway Company Details
  • 13.6.2 Amway Business Overview and Its Total Revenue
  • 13.6.3 Amway Marine Drug Introduction
  • 13.6.4 Amway Revenue in Marine Drug Business (2015-2020)
  • 13.6.5 Amway Recent Development
• 13.7 Pfizer
  • 13.7.1 Pfizer Company Details
  • 13.7.2 Pfizer Business Overview and Its Total Revenue
  • 13.7.3 Pfizer Marine Drug Introduction
  • 13.7.4 Pfizer Revenue in Marine Drug Business (2015-2020)
  • 13.7.5 Pfizer Recent Development
• 13.8 Pelagia (EPAX)
  • 13.8.1 Pelagia (EPAX) Company Details
  • 13.8.2 Pelagia (EPAX) Business Overview and Its Total Revenue
  • 13.8.3 Pelagia (EPAX) Marine Drug Introduction
  • 13.8.4 Pelagia (EPAX) Revenue in Marine Drug Business (2015-2020)
  • 13.8.5 Pelagia (EPAX) Recent Development
• 13.9 Pharma Mar SA
  • 13.9.1 Pharma Mar SA Company Details
  • 13.9.2 Pharma Mar SA Business Overview and Its Total Revenue
  • 13.9.3 Pharma Mar SA Marine Drug Introduction
  • 13.9.4 Pharma Mar SA Revenue in Marine Drug Business (2015-2020)
  • 13.9.5 Pharma Mar SA Recent Development
• 13.10 Croda
  • 13.10.1 Croda Company Details
  • 13.10.2 Croda Business Overview and Its Total Revenue
  • 13.10.3 Croda Marine Drug Introduction
  • 13.10.4 Croda Revenue in Marine Drug Business (2015-2020)
  • 13.10.5 Croda Recent Development
• 13.11 GNC
  • 10.11.1 GNC Company Details
  • 10.11.2 GNC Business Overview and Its Total Revenue
  • 10.11.3 GNC Marine Drug Introduction
  • 10.11.4 GNC Revenue in Marine Drug Business (2015-2020)
  • 10.11.5 GNC Recent Development
• 13.12 GSK
  • 10.12.1 GSK Company Details
  • 10.12.2 GSK Business Overview and Its Total Revenue
  • 10.12.3 GSK Marine Drug Introduction
  • 10.12.4 GSK Revenue in Marine Drug Business (2015-2020)
  • 10.12.5 GSK Recent Development
• 13.13 TerSera Therapeutics
  • 10.13.1 TerSera Therapeutics Company Details
  • 10.13.2 TerSera Therapeutics Business Overview and Its Total Revenue
  • 10.13.3 TerSera Therapeutics Marine Drug Introduction
  • 10.13.4 TerSera Therapeutics Revenue in Marine Drug Business (2015-2020)
  • 10.13.5 TerSera Therapeutics Recent Development
• 13.14 Nordic Naturals
  • 10.14.1 Nordic Naturals Company Details
  • 10.14.2 Nordic Naturals Business Overview and Its Total Revenue
  • 10.14.3 Nordic Naturals Marine Drug Introduction
  • 10.14.4 Nordic Naturals Revenue in Marine Drug Business (2015-2020)
  • 10.14.5 Nordic Naturals Recent Development
• 13.15 Carlson Labs
  • 10.15.1 Carlson Labs Company Details
  • 10.15.2 Carlson Labs Business Overview and Its Total Revenue
  • 10.15.3 Carlson Labs Marine Drug Introduction
  • 10.15.4 Carlson Labs Revenue in Marine Drug Business (2015-2020)
  • 10.15.5 Carlson Labs Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer